TrialPloS one2018

Experiences with long acting injectable ART: A qualitative study among PLHIV participating in a Phase II study of cabotegravir + rilpivirine (LATTE-2) in the United States and Spain.

Deanna Kerrigan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.